FDAnews
www.fdanews.com/articles/115255-fda-rejects-appeal-regarding-genasense

FDA Rejects Appeal Regarding Genasense

March 9, 2009
Genta Incorporated announced that the FDA Center for Drug Evaluation and Research has decided that available data are not adequate to support approval of Genasense (oblimersen sodium) Injection for treatment of patients with relapsed or refractory chronic lymphocytic leukemia.
TradingMarkets